Your browser doesn't support javascript.
loading
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
Murray, Daniel D; Babiker, Abdel G; Baker, Jason V; Barkauskas, Christina E; Brown, Samuel M; Chang, Christina C; Davey, Victoria J; Gelijns, Annetine C; Ginde, Adit A; Grund, Birgit; Higgs, Elizabeth; Hudson, Fleur; Kan, Virginia L; Lane, H Clifford; Murray, Thomas A; Paredes, Roger; Parmar, Mahesh Kb; Pett, Sarah; Phillips, Andrew N; Polizzotto, Mark N; Reilly, Cavan; Sandkovsky, Uriel; Sharma, Shweta; Teitelbaum, Marc; Thompson, B Taylor; Young, Barnaby E; Neaton, James D; Lundgren, Jens D.
Afiliação
  • Murray DD; CHIP Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
  • Babiker AG; Medical Research Council Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Baker JV; Hennepin Healthcare Research Institute, Minneapolis, MN, USA.
  • Barkauskas CE; Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Brown SM; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University, Durham, NC, USA.
  • Chang CC; Intermountain Medical Center, Murray, UT, USA.
  • Davey VJ; University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Gelijns AC; The Kirby Institute, University of New South Wales Sydney, Sydney, NSW, Australia.
  • Ginde AA; U.S. Department of Veterans Affairs, Washington, DC, USA.
  • Grund B; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Higgs E; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
  • Hudson F; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Kan VL; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Lane HC; Medical Research Council Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Murray TA; Veteran Affairs Medical Center, Washington, DC, USA.
  • Paredes R; School of Medicine & Health Sciences, The George Washington University, Washington, DC, USA.
  • Parmar MK; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Pett S; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Phillips AN; Infectious Diseases Department & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Catalonia, Spain.
  • Polizzotto MN; Medical Research Council Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Reilly C; Medical Research Council Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Sandkovsky U; Institute for Global Health, University College London, London, UK.
  • Sharma S; CHIP Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
  • Teitelbaum M; Institute for Global Health, University College London, London, UK.
  • Thompson BT; The Kirby Institute, University of New South Wales Sydney, Sydney, NSW, Australia.
  • Young BE; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.
  • Neaton JD; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Lundgren JD; Division of Infectious Diseases, Baylor University Medical Center, Dallas, TX, USA.
Clin Trials ; 19(1): 52-61, 2022 02.
Article em En | MEDLINE | ID: mdl-34632800
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article